[go: up one dir, main page]

CN111317867A - Nerve conduit and preparation method thereof - Google Patents

Nerve conduit and preparation method thereof Download PDF

Info

Publication number
CN111317867A
CN111317867A CN202010081724.9A CN202010081724A CN111317867A CN 111317867 A CN111317867 A CN 111317867A CN 202010081724 A CN202010081724 A CN 202010081724A CN 111317867 A CN111317867 A CN 111317867A
Authority
CN
China
Prior art keywords
collagen
nerve
nerve conduit
mineral
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010081724.9A
Other languages
Chinese (zh)
Inventor
王秀梅
王硕
段古满
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsinghua University
Original Assignee
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsinghua University filed Critical Tsinghua University
Priority to CN202010081724.9A priority Critical patent/CN111317867A/en
Publication of CN111317867A publication Critical patent/CN111317867A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a nerve conduit and a preparation method thereof, wherein the main components of the nerve conduit are collagen which can be desorbed and absorbed in an organism and minerals rich in calcium ions, and the nerve conduit has good biocompatibility and calcium ion release performance. It has a multilayer structure with each layer having a trench-like microstructure. The multilayer catheter is formed by collagen gel film and is curled into a circular tube shape, the manufacturing is simple and convenient, the catheter contains calcium ion mineral materials, inorganic ion elements are released in a micro-scale mode, and the promoting effect is provided for the regeneration of nerves, blood vessels and the like. Clinically, after peripheral nerve injury, the nerve conduit provided by the invention can be used for bypass surgery, and gradually descends and absorbs in organisms while nerve regeneration. The invention has good toughness and strength due to the adoption of a multilayer structure, and has certain porosity by adjusting the moisture content in the forming process, thereby being beneficial to the transportation of nutrient substances and metabolites during nerve repair.

Description

一种神经导管及其制备方法A kind of nerve conduit and preparation method thereof

技术领域technical field

本文涉及生物医用材料技术,具体为一种神经导管及其制备方法,尤指一种缓释钙离子的具有微纳结构胶原神经导管及其制备方法。This article relates to biomedical material technology, in particular to a nerve conduit and a preparation method thereof, in particular to a collagen nerve conduit with a micro-nano structure that slowly releases calcium ions and a preparation method thereof.

背景技术Background technique

周围神经缺损是临床最常见的创伤之一,据报道每年其发生例数占创伤病人的1.5%~4.0%,国内高达60万~90万例/年。临床上,相较于皮肤、软组织、关节、骨等损伤,神经损伤处理更为困难,恢复期长,缺乏有效措施,有时预后不理想。神经损伤会使受累神经所支配的远端肢体出现完全的感觉和/或运动功能的缺失,如果断端损伤且未经有效手段修复,随着时间的推移,周围结缔组织会阻碍神经生长修复,形成神经瘤样组织,最终造成无法逆转的功能障碍,导致严重肢体残疾,给患者的工作及生活都带来巨大的损害。Peripheral nerve defect is one of the most common clinical traumas. It is reported that the number of cases that occur every year accounts for 1.5% to 4.0% of trauma patients, and the number of cases in China is as high as 600,000 to 900,000 cases per year. Clinically, compared with skin, soft tissue, joint, bone and other injuries, the treatment of nerve injury is more difficult, the recovery period is long, there is a lack of effective measures, and the prognosis is sometimes unsatisfactory. Nerve damage can cause complete loss of sensory and/or motor function in the distal limbs innervated by the affected nerve. If the broken end is damaged and not repaired by effective means, the surrounding connective tissue will hinder nerve growth and repair over time. The formation of neuroma-like tissue will eventually cause irreversible dysfunction, resulting in severe physical disability, and bring huge damage to the patient's work and life.

短距离缺损可以进行神经断端直接无张力吻合。而长距离缺损的修复,是临床上是比较困难的。目前最常用的方法是利用自体神经移植桥接修复神经断端,即使该方法被认为是临床工作的“金标准”,其仍有许多缺点:诸如神经来源有限,供体神经的功能受损,供区手术疤痕形成及感染风险等,且研究表明,只有40%~50%的病人在接受自体神经移植后能实现运动功能的完全恢复,所以需要寻找替代自体神经移植的方法。For short-distance defects, direct tension-free anastomosis of the nerve stump can be performed. The repair of long-distance defects is clinically difficult. At present, the most commonly used method is to use autologous nerve grafts to bridge the repair of nerve stumps. Even though this method is considered to be the "gold standard" for clinical work, it still has many disadvantages: such as limited nerve sources, impaired function of the donor nerve, In addition, studies have shown that only 40% to 50% of patients can achieve complete recovery of motor function after receiving autologous nerve transplantation, so it is necessary to find an alternative to autologous nerve transplantation.

随着生物医用材料和组织工程学的迅速发展,人们将研究的重点转向使用神经导管桥接缺损神经的两断端,促进周围神经修复。如,化学材料聚乙烯、聚乙醇酸、聚乳酸等;生物材料壳聚糖、明胶等;生物体管状支架动脉、静脉和肌膜管等都曾被试图用来制备导管。但由于化学材料生物相容性较差,生物材料及生物体管的力学性能较差等一系列的问题,其修复效果不佳,临床应用局限。With the rapid development of biomedical materials and tissue engineering, the focus of research has turned to the use of nerve conduits to bridge the two broken ends of defective nerves to promote peripheral nerve repair. For example, chemical materials polyethylene, polyglycolic acid, polylactic acid, etc.; biological materials chitosan, gelatin, etc.; biological tubular stent arteries, veins and sarcolemmal tubes have all been tried to prepare catheters. However, due to a series of problems such as poor biocompatibility of chemical materials, poor mechanical properties of biological materials and biological tubes, etc., the repair effect is not good, and its clinical application is limited.

目前,研究的重点是在结构相对简单的神经导管,其修复长神经缺损效果确切。且经CFDA批准临床应用神经导管产品绝大多数为此类。但大多数此类神经导管很难兼顾良好的机械强度(手术操作及阻隔软组织长入)、良好的生物相容性(细胞及营养物质代谢运输)、可控的体内降解(体内降解不佳)或无法提供修复所需的生物促进作用(功能单一,仅物理桥接神经断端),不能更好的促进神经再生。At present, the research focuses on the relatively simple structure of the nerve conduit, which has a precise effect on repairing long nerve defects. And the vast majority of nerve catheter products approved by CFDA for clinical application are of this type. However, it is difficult for most of these nerve conduits to take into account good mechanical strength (surgical operation and blocking soft tissue ingrowth), good biocompatibility (metabolic transport of cells and nutrients), and controllable in vivo degradation (poor degradation in vivo) Or it cannot provide the biological boosting effect required for repair (single function, only physically bridging nerve stumps), and cannot better promote nerve regeneration.

临床上长期期盼一种制备过程简单、机械强度适宜、生物相容性能好、方便体内降解、且方便、安全、有效的周围神经修复材料的出现。Clinically, the appearance of a peripheral nerve repair material with simple preparation process, suitable mechanical strength, good biocompatibility, convenient in vivo degradation, and convenient, safe and effective has been long-awaited in clinic.

发明内容SUMMARY OF THE INVENTION

本发明提供了一种神经导管及其制备方法,所述神经导管由胶原凝胶成膜卷曲成圆管状,制作简单方便,导管含有矿物材料,微量释放无机离子元素,为神经及血管等的再生提供促进作用,促进神经轴突生长,同时钙离子随材料降解释放,避免局部钙离子浓度陡增,不影响雪旺细胞在神经再生中的重要作用,使管内的神经组织能够更好地生长。同时,附着矿化胶原导管避免纯胶原导管降解过快,使得导管降解速度易于调控。The invention provides a nerve conduit and a preparation method thereof. The nerve conduit is formed of collagen gel and rolled into a circular tube, which is simple and convenient to manufacture. The conduit contains mineral materials and releases inorganic ion elements in a small amount, which is used for regeneration of nerves and blood vessels. Provides a stimulatory effect, promotes the growth of nerve axons, and at the same time calcium ions are released with the degradation of the material, avoiding a sudden increase in the local calcium ion concentration, without affecting the important role of Schwann cells in nerve regeneration, so that the nerve tissue in the tube can grow better. At the same time, the mineralized collagen catheter is attached to avoid excessive degradation of the pure collagen catheter, so that the degradation rate of the catheter can be easily regulated.

本发明的目的是提供一种缓释钙离子的具有微纳结构胶原神经导管及其制备方法。The purpose of the present invention is to provide a collagen nerve conduit with a micro-nano structure and a preparation method thereof with slow-release calcium ions.

本发明所提供的人工神经导管,其主要成分为生物体内可分解吸收的胶原蛋白及富含钙离子的矿物,其具有良好的生物相容性及钙离子释放性能。其具有多层结构,每层具有沟槽状微观结构。The artificial nerve conduit provided by the present invention is mainly composed of decomposable and absorbable collagen and calcium ion-rich minerals in vivo, and has good biocompatibility and calcium ion release performance. It has a multi-layer structure, each layer has a groove-like microstructure.

最新研究表明,钙离子神经修复中起重要作用,钙离子不但能够加速损伤神经轴突生长,同时还参与体内其他代谢活动(Adalbert R,Morreale G,Paizs M,Conforti L,Walker SA,Roderick HL,Bootman MD,Siklóikl SiklD,Sikloderick HL,Bootman MD,SiklMD,SiklSaxotomy in wild-type and slow Wallerian degenerationaxons.Neuroscience.2012;225:44-54.)。然而,研究人员发现体外培养基中钙离子浓度的陡增,雪旺细胞存活率将受到影响,而雪旺细胞在神经再生和恢复中发挥重要作用(YangKJ,Yan Y,Zhang LL,Agresti MA,Matloub HS,LoGiudice JA,Havlik R,YanJG.Increasing Calcium Level Limits Schwann Cell Numbers In Vitro followingPeripheral Nerve Injury.Journal of Reconstructive Microsurgery.2017;33:435-40.)。The latest research shows that calcium ions play an important role in nerve repair. Calcium ions can not only accelerate the growth of damaged nerve axons, but also participate in other metabolic activities in the body (Adalbert R, Morreale G, Paizs M, Conforti L, Walker SA, Roderick HL, Bootman MD, Siklóikl Sikl D, Sikloderick HL, Bootman MD, Sikl MD, Sikl Saxotomy in wild-type and slow Wallerian degenerationaxons. Neuroscience. 2012;225:44-54.). However, the researchers found that the sharp increase of calcium ion concentration in the in vitro medium will affect the survival rate of Schwann cells, and Schwann cells play an important role in nerve regeneration and recovery (Yang KJ, Yan Y, Zhang LL, Agresti MA, Matloub HS, LoGiudice JA, Havlik R, Yan JG. Increasing Calcium Level Limits Schwann Cell Numbers In Vitro following Peripheral Nerve Injury. Journal of Reconstructive Microsurgery. 2017;33:435-40.).

本发明提供了一种神经导管,所述神经导管为I型胶原蛋白水凝胶和矿物材料混合后凝固制备成的膜,再经过卷曲形成的导管;The invention provides a nerve conduit. The nerve conduit is a membrane prepared by mixing type I collagen hydrogel and a mineral material and then coagulating, and then curling to form a conduit;

可选地,制备成的膜的表面具有微米尺度或纳米尺度的沟槽结构,所述膜的含有沟槽结构的面用于神经导管的内壁;Optionally, the surface of the prepared film has a micro-scale or nano-scale groove structure, and the surface of the film containing the groove structure is used for the inner wall of the nerve conduit;

优选地,所述沟槽结构的尺寸为长500-25000μm,宽5-25μm,深5-25μm,间距5-25μm,或者长10-20μm,宽100-200nm,深100-200nm,间距100-200nm。Preferably, the size of the trench structure is 500-25000 μm in length, 5-25 μm in width, 5-25 μm in depth, and 5-25 μm in pitch, or 10-20 μm in length, 100-200 nm in width, 100-200 nm in depth, and 100- 200nm.

在本发明提供的神经导管中,所述卷曲形成的导管的管壁经过物理或化学方法增强不同膜层之间的固定;In the nerve conduit provided by the present invention, the wall of the conduit formed by crimping enhances the fixation between different membrane layers through physical or chemical methods;

优选地,所述化学方法为使用交联剂对胶原蛋白进行交联。Preferably, the chemical method is to cross-link the collagen using a cross-linking agent.

在本发明提供的神经导管中,所述神经导管的导管内径为1-5mm;导管长度为10-30mm;所述卷曲形成的导管中,管壁中膜的层数依据所需强度及降解效率为2-6层。In the nerve conduit provided by the present invention, the inner diameter of the conduit of the nerve conduit is 1-5 mm; the length of the conduit is 10-30 mm; in the conduit formed by crimping, the number of layers of the membrane in the tube wall depends on the required strength and degradation efficiency For 2-6 layers.

在本发明提供的神经导管中,所述矿物材料和I型胶原蛋白水凝胶的质量比为1:(1-10)。In the nerve conduit provided by the present invention, the mass ratio of the mineral material to the type I collagen hydrogel is 1:(1-10).

在本发明提供的神经导管中,所述矿物材料包括β磷酸三钙、纳米羟基磷灰石和仿生矿化胶原中的一种或多种;可选地,矿物材料种类还可以是含其他有益元素(镁、硅、硒、锌等)的羟基磷灰石。In the nerve conduit provided by the present invention, the mineral material includes one or more of β-tricalcium phosphate, nano-hydroxyapatite and biomimetic mineralized collagen; optionally, the mineral material may also contain other beneficial Hydroxyapatite of elements (magnesium, silicon, selenium, zinc, etc.).

在本发明提供的神经导管中,优选地,所述矿物材料的粒度为50-100nm。In the nerve conduit provided by the present invention, preferably, the particle size of the mineral material is 50-100 nm.

在本发明提供的神经导管中,所述I型胶原蛋白水凝胶和矿物材料与水混合后通过模具制备成膜;In the nerve conduit provided by the present invention, the type I collagen hydrogel and the mineral material are mixed with water to prepare a film through a mold;

在本发明提供的神经导管中,可选地,水的加入量为I型胶原蛋白水凝胶、矿物材料和水总体积的0%-50%。In the nerve conduit provided by the present invention, optionally, the amount of water added is 0%-50% of the total volume of the type I collagen hydrogel, mineral material and water.

在本发明提供的神经导管中,所述通过模具制备成膜包括以下步骤,In the nerve conduit provided by the present invention, the preparation of the film by the mold comprises the following steps:

将I型胶原蛋白水凝胶和矿物材料与水混合后形成的溶液倒入模具中,经过负压抽真空排除内部气泡,后经过干燥形成膜状材料;The solution formed by mixing type I collagen hydrogel and mineral material with water is poured into the mold, and the internal air bubbles are removed by vacuuming with negative pressure, and then a film-like material is formed after drying;

可选地,所述负压抽真空的压强为-0~-0.1MPa。Optionally, the pressure of the negative pressure vacuuming is -0 to -0.1 MPa.

在本发明提供的神经导管中,所述交联剂选自戊二醛、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)、环氧交联剂和京尼平中第一种或多种;In the nerve conduit provided by the present invention, the cross-linking agent is selected from glutaraldehyde, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), epoxy cross-linking agent One or more of the combination agent and genipin;

所述环氧交联剂选自环氧乙烷和环氧氯丙烷中的一种或多种。The epoxy crosslinking agent is selected from one or more of ethylene oxide and epichlorohydrin.

另一方面,本发明提供了上述的神经导管的制备方法,包括以下操作步骤:On the other hand, the present invention provides the preparation method of the above-mentioned nerve conduit, comprising the following operation steps:

步骤S1-1:将I型胶原蛋白水凝胶与矿物材料混合,得到矿物材料/I型胶原蛋白水凝胶混合物;Step S1-1: mixing type I collagen hydrogel and mineral material to obtain a mineral material/type I collagen hydrogel mixture;

步骤S1-2:将步骤S1-1中得到的矿物材料/I型胶原蛋白水凝胶混合物与水混合,得到矿物胶原溶液;通过调整总体的含水量,可以调整神经导管的孔隙率和降解速度。Step S1-2: Mix the mineral material/type I collagen hydrogel mixture obtained in step S1-1 with water to obtain a mineral collagen solution; by adjusting the overall water content, the porosity and degradation rate of the nerve conduit can be adjusted .

步骤S2-1:取步骤S1-2中得到的矿物胶原溶液倒入模具,经过负压抽真空排除内部气泡,后经过干燥形成膜状的矿物胶原薄膜;Step S2-1: take the mineral collagen solution obtained in step S1-2 and pour it into a mold, remove internal air bubbles through negative pressure vacuuming, and then dry to form a film-like mineral collagen film;

步骤S2-2:取步骤S2-1所得矿物胶原薄膜,均匀涂抹S1-2所得矿物胶原溶液的稀释液进行软化,卷曲成管状,并干燥直至完全定型;干燥的胶原膜要卷成管需要稀释的矿物胶原溶液作为粘结剂。Step S2-2: take the mineral collagen film obtained in step S2-1, evenly apply the dilution of the mineral collagen solution obtained in step S1-2 for softening, curl it into a tube shape, and dry it until it is completely shaped; the dried collagen film needs to be diluted to be rolled into a tube of mineral collagen solution as a binder.

步骤S2-3:取步骤S2-2所得完全定型的管状产物,经交联剂交联后即得神经导管;Step S2-3: take the fully shaped tubular product obtained in step S2-2, and cross-link with a cross-linking agent to obtain a nerve conduit;

可选地,步骤S2-3还包括对交联剂交联后的产物进行洗脱、冻干处理,再采用辐照的方式对产品进行灭菌,制得胶原多层神经导管。Optionally, step S2-3 further includes eluting and freeze-drying the product cross-linked by the cross-linking agent, and then sterilizing the product by irradiation to prepare a collagen multilayer nerve conduit.

在本发明提供的神经导管的制备方法中,所述模具中与矿物胶原溶液接触的一侧具有微米或纳米尺度的沟槽结构;In the preparation method of the nerve conduit provided by the present invention, the side in contact with the mineral collagen solution in the mold has a micro- or nano-scale groove structure;

在本发明提供的神经导管的制备方法中,可选地,所述模具的材质采用单晶硅,在单晶硅表面通过干法刻蚀刻蚀出所述沟槽结构,或者所述纳米尺度的沟槽结构采用二甲基硅氧烷(PDMS)转模的方式将结构附加在矿化胶原薄膜。In the preparation method of the nerve conduit provided by the present invention, optionally, the material of the mold is monocrystalline silicon, and the groove structure is etched on the surface of the monocrystalline silicon by dry etching, or the nanoscale The groove structure is attached to the mineralized collagen film by means of dimethylsiloxane (PDMS) transfer molding.

在本发明提供的神经导管的制备方法中,所述步骤S2-1中矿物胶原溶液倒入模具中风干前厚度为3-10mm;In the preparation method of the nerve conduit provided by the present invention, in the step S2-1, the mineral collagen solution is poured into the mold and the thickness is 3-10mm before air-drying;

在本发明提供的神经导管的制备方法中,可选地,所述矿物胶原溶液含量为0.5-1g/cm2In the preparation method of the nerve conduit provided by the present invention, optionally, the content of the mineral collagen solution is 0.5-1 g/cm 2 ;

在本发明提供的神经导管的制备方法中,可选地,所述干燥为风干,所述风干温度不低于室温,而且不高于30℃;In the preparation method of the nerve conduit provided by the present invention, optionally, the drying is air-drying, and the air-drying temperature is not lower than room temperature and not higher than 30°C;

可选地,根据风干时间不同,干燥程度可以控制(含最终水量不同),风干后膜厚度0.1-1mm。可以采取分层干燥的工艺,逐步添加含有不同矿物种类(β磷酸三钙,纳米羟基磷灰石,矿化胶原)矿物胶原溶液进行单张膜的制备,使其具有更高级的多种成分的结构。Optionally, depending on the air-drying time, the degree of drying can be controlled (the final water content is different), and the film thickness after air-drying is 0.1-1 mm. The process of layering and drying can be adopted, and the mineral collagen solution containing different mineral species (β-tricalcium phosphate, nano-hydroxyapatite, mineralized collagen) can be gradually added to prepare a single film, so that it has more advanced multi-component properties. structure.

在本发明提供的神经导管的制备方法中,可选地,干燥后形成的矿物胶原薄膜的厚度0.1-1mm。In the preparation method of the nerve conduit provided by the present invention, optionally, the thickness of the mineral collagen film formed after drying is 0.1-1 mm.

在本发明提供的神经导管的制备方法中,所述步骤S2-2中,所述矿物胶原溶液稀释液使用去离子水按体积比稀释,所述稀释浓度为1:(1~10)。In the preparation method of the nerve conduit provided by the present invention, in the step S2-2, the mineral collagen solution diluent is diluted by volume with deionized water, and the dilution concentration is 1:(1-10).

在本发明提供的神经导管的制备方法中,所述步骤S2-3中,洗脱先用乙醇水溶液清洗3~10次,再用纯化水清洗3~10次,其中乙醇水溶液乙醇体积浓度范围为30%-100%。In the preparation method of the nerve conduit provided by the present invention, in the step S2-3, the elution is first washed with an ethanol aqueous solution for 3-10 times, and then washed with purified water for 3-10 times, wherein the ethanol volume concentration range of the ethanol aqueous solution is: 30%-100%.

在本发明提供的神经导管的制备方法中,在步骤S2-3中所述冻干处理具体为:将洗脱后得到的产物先在-30~-20℃的条件下进行预冻,再在真空、-10~0℃的条件下进行升华造孔,孔径范围为0-10μm,最后在0~50℃下进行真空干燥;In the preparation method of the nerve conduit provided by the present invention, the freeze-drying treatment in step S2-3 is specifically: pre-freezing the product obtained after elution at -30 to -20°C, and then Under the conditions of vacuum and -10~0℃, sublimation is carried out to make pores, and the pore size range is 0-10μm, and finally vacuum drying is carried out at 0~50℃;

优选地,所述孔径范围为1μm-10μm。Preferably, the pore size ranges from 1 μm to 10 μm.

在本发明提供的神经导管的制备方法中,在步骤S2-3所述交联的交联时间为20min~4h;In the preparation method of the nerve conduit provided by the present invention, the cross-linking time of the cross-linking in step S2-3 is 20min-4h;

可选地,所述辐照所用的试剂为钴-60灭菌剂,剂量为15~38kGy。Optionally, the reagent used for the irradiation is cobalt-60 sterilant, and the dose is 15-38 kGy.

本发明的有益效果如下:The beneficial effects of the present invention are as follows:

本发明提供的多层人工神经导管可以通过手术植入神经损伤的部位。当用于周围神经损伤修复时,可以依据损伤神经的粗细及缺损程度选取适当规格层厚的导管,将离断的神经两断端插入到导管内约2-5毫米并用手术缝线进行神经外模缝合固定。The multi-layer artificial nerve conduit provided by the present invention can be surgically implanted into the site of nerve injury. When used for the repair of peripheral nerve injury, a catheter with an appropriate thickness can be selected according to the thickness of the injured nerve and the degree of defect, and the two ends of the severed nerve are inserted into the catheter about 2-5 mm, and surgical sutures are used for extra-neural surgery. Die stitched to fix.

临床上,周围神经以后可以采用本发明的多层人工神经导管进行桥接手术,并在神经再生完成后,在体内逐步降解吸收。与其他神经导管对比,本发明的人工神经导管采用多层结构,导管韧性佳,可耐受缝线的剪切力也可阻碍周围软组织长入影响修复效果。导管可微量缓慢释放钙离子,加速轴突生长,桥接手术后神经的再生速度快,质量好。附着矿化胶原导管避免纯胶原导管降解过快,使得导管降解速度易于调控。另外,本发明术后无需二次手术取出植入物,降解时间与神经纤维生长的速度相适应,可以应用于临床周围神经损伤的修复。Clinically, peripheral nerves can be bridged with the multilayer artificial nerve conduit of the present invention later, and after the nerve regeneration is completed, it is gradually degraded and absorbed in the body. Compared with other nerve conduits, the artificial nerve conduit of the present invention adopts a multi-layer structure, the conduit has good toughness, can withstand the shear force of the suture, and can also hinder the ingrowth of the surrounding soft tissue and affect the repair effect. The catheter can slowly release calcium ions in a small amount, accelerate the growth of axons, and the regeneration of nerves after bridging surgery is fast and of good quality. Attaching the mineralized collagen conduits avoids excessive degradation of pure collagen conduits, making the degradation rate of the conduits easy to control. In addition, the present invention does not require a second operation to take out the implant after operation, the degradation time is adapted to the growth speed of nerve fibers, and can be applied to the repair of clinical peripheral nerve injury.

本发明的其它特征和优点将在随后的说明书中阐述,并且,部分地从说明书中变得显而易见,或者通过实施本发明而了解。本发明的其他优点可通过在说明书中所描述的方案来发明实现和获得。Other features and advantages of the present invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the invention. Other advantages of the present invention may be realized and obtained by means of the arrangements described in the specification.

附图说明Description of drawings

附图用来提供对本发明技术方案的理解,并且构成说明书的一部分,与本发明的实施例一起用于解释本发明的技术方案,并不构成对本发明技术方案的限制。The accompanying drawings are used to provide an understanding of the technical solutions of the present invention, and constitute a part of the specification, and together with the embodiments of the present invention, they are used to explain the technical solutions of the present invention, and do not limit the technical solutions of the present invention.

图1为仿生矿化胶原-胶原多层神经导管结构模式图;Figure 1 is a schematic diagram of the structure of the biomimetic mineralized collagen-collagen multilayer nerve conduit;

图2为实施例1制备的仿生矿化胶原-胶原多层神经导管实物图;Fig. 2 is the actual picture of the biomimetic mineralized collagen-collagen multilayer nerve conduit prepared in Example 1;

图3为实施例1制备的导管壁侧面的扫描式电子显微镜图;Fig. 3 is the scanning electron microscope picture of the side surface of the catheter wall prepared in Example 1;

图4为术中导管植入大鼠坐骨神经;Figure 4 shows the intraoperative catheter implantation into the rat sciatic nerve;

图5为术后桥接神经免疫荧光(神经丝蛋白NF200),导管植入促进大鼠坐骨神经轴突生长;Figure 5 shows the post-operative bridging nerve immunofluorescence (neurofilament protein NF200), and catheter implantation promotes the growth of rat sciatic nerve axons;

图6三组不同方式修复大鼠坐骨神经,术后12周修复神经中点超薄切片透射电镜观察。A自体神经组;B矿化胶原-胶原多层神经导管组;C纯胶原蛋白导管组。(上:2550x,下:26500x)。Fig. 6 The sciatic nerves of rats were repaired in different ways in three groups, and 12 weeks after the operation, the ultrathin sections of the repaired nerves were observed by transmission electron microscopy. A autologous nerve group; B mineralized collagen-collagen multilayer nerve conduit group; C pure collagen conduit group. (Top: 2550x, Bottom: 26500x).

具体实施方式Detailed ways

为使本发明的目的、技术方案和优点更加清楚明白,下文对本发明的实施例进行详细说明。需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互任意组合。In order to make the objectives, technical solutions and advantages of the present invention clearer, the embodiments of the present invention are described in detail below. It should be noted that the embodiments of the present invention and the features of the embodiments may be arbitrarily combined with each other unless there is conflict.

本发明实施例中提供了一种神经导管,所述神经导管为I型胶原蛋白水凝胶和矿物材料混合后凝固制备成的膜,再经过卷曲形成的导管;In the embodiment of the present invention, a nerve conduit is provided, and the nerve conduit is a membrane prepared by mixing type I collagen hydrogel and a mineral material and then coagulating, and then a conduit formed by crimping;

可选地,制备成的膜的表面具有微米尺度或纳米尺度的沟槽结构,所述膜的含有沟槽结构的面用于神经导管的内壁;Optionally, the surface of the prepared film has a micro-scale or nano-scale groove structure, and the surface of the film containing the groove structure is used for the inner wall of the nerve conduit;

优选地,所述沟槽结构的尺寸为长500-25000μm,宽5-25μm,深5-25μm,间距5-25μm,或者长10-20μm,宽100-200nm,深100-200nm,间距100-200nm。Preferably, the size of the trench structure is 500-25000 μm in length, 5-25 μm in width, 5-25 μm in depth, and 5-25 μm in pitch, or 10-20 μm in length, 100-200 nm in width, 100-200 nm in depth, and 100- 200nm.

在本发明实施例中,所述卷曲形成的导管的管壁经过物理或化学方法增强不同膜层之间的固定;In the embodiment of the present invention, the wall of the conduit formed by crimping enhances the fixation between different membrane layers through physical or chemical methods;

优选地,所述化学方法为使用交联剂对胶原蛋白进行交联。Preferably, the chemical method is to cross-link the collagen using a cross-linking agent.

在本发明实施例中,所述神经导管的导管内径为1-5mm;导管长度为10-30mm;所述卷曲形成的导管中,管壁中膜的层数依据所需强度及降解效率为2-6层。In the embodiment of the present invention, the inner diameter of the conduit of the nerve conduit is 1-5 mm; the length of the conduit is 10-30 mm; in the conduit formed by crimping, the number of layers of the membrane in the tube wall is 2 according to the required strength and degradation efficiency -layer 6.

在本发明实施例中,所述矿物材料和I型胶原蛋白水凝胶的质量比为1:(1-10)。In the embodiment of the present invention, the mass ratio of the mineral material and the type I collagen hydrogel is 1:(1-10).

在本发明实施例中,所述矿物材料包括β磷酸三钙、纳米羟基磷灰石和仿生矿化胶原中的一种或多种;可选地,矿物材料种类还可以是含其他有益元素(镁、硅、硒、锌等)的羟基磷灰石。In the embodiment of the present invention, the mineral material includes one or more of β-tricalcium phosphate, nano-hydroxyapatite and biomimetic mineralized collagen; optionally, the mineral material may also contain other beneficial elements ( hydroxyapatite of magnesium, silicon, selenium, zinc, etc.).

在本发明实施例中,优选地,所述矿物材料的粒度为50-100nm。In the embodiment of the present invention, preferably, the particle size of the mineral material is 50-100 nm.

在本发明实施例中,所述I型胶原蛋白水凝胶和矿物材料与水混合后通过模具制备成膜;In the embodiment of the present invention, the type I collagen hydrogel and the mineral material are mixed with water to prepare a film through a mold;

在本发明实施例中,可选地,水的加入量为I型胶原蛋白水凝胶、矿物材料和水总体积的0%-50%。In the embodiment of the present invention, optionally, the added amount of water is 0%-50% of the total volume of the type I collagen hydrogel, mineral material and water.

在本发明实施例中,所述通过模具制备成膜包括以下步骤,In the embodiment of the present invention, the preparation of the film by the mold includes the following steps:

将I型胶原蛋白水凝胶和矿物材料与水混合后形成的溶液倒入模具中,经过负压抽真空排除内部气泡,后经过干燥形成膜状材料;The solution formed by mixing type I collagen hydrogel and mineral material with water is poured into the mold, and the internal air bubbles are removed by vacuuming with negative pressure, and then a film-like material is formed after drying;

可选地,所述负压抽真空的压强为-0~-0.1MPa。Optionally, the pressure of the negative pressure vacuuming is -0 to -0.1 MPa.

在本发明实施例中,所述交联剂选自戊二醛、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)、环氧交联剂和京尼平中第一种或多种;In the embodiment of the present invention, the cross-linking agent is selected from glutaraldehyde, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), epoxy cross-linking agent and one or more of Genipin;

所述环氧交联剂选自环氧乙烷和环氧氯丙烷中的一种或多种。The epoxy crosslinking agent is selected from one or more of ethylene oxide and epichlorohydrin.

另一方面,本发明实施例提供了上述的神经导管的制备方法,包括以下操作步骤:On the other hand, the embodiment of the present invention provides the preparation method of the above-mentioned nerve conduit, comprising the following operation steps:

步骤S1-1:将I型胶原蛋白水凝胶与矿物材料混合,得到矿物材料/I型胶原蛋白水凝胶混合物;Step S1-1: mixing type I collagen hydrogel and mineral material to obtain a mineral material/type I collagen hydrogel mixture;

步骤S1-2:将步骤S1-1中得到的矿物材料/I型胶原蛋白水凝胶混合物与水混合,得到矿物胶原溶液;通过调整总体的含水量,可以调整神经导管的孔隙率和降解速度。Step S1-2: Mix the mineral material/type I collagen hydrogel mixture obtained in step S1-1 with water to obtain a mineral collagen solution; by adjusting the overall water content, the porosity and degradation rate of the nerve conduit can be adjusted .

步骤S2-1:取步骤S1-2中得到的矿物胶原溶液倒入模具,经过负压抽真空排除内部气泡,后经过干燥形成膜状的矿物胶原薄膜;Step S2-1: take the mineral collagen solution obtained in step S1-2 and pour it into a mold, remove internal air bubbles through negative pressure vacuuming, and then dry to form a film-like mineral collagen film;

步骤S2-2:取步骤S2-1所得矿物胶原薄膜,均匀涂抹S1-2所得矿物胶原溶液的稀释液进行软化,卷曲成管状,并干燥直至完全定型;干燥的胶原膜要卷成管需要稀释的矿物胶原溶液作为粘结剂。Step S2-2: take the mineral collagen film obtained in step S2-1, evenly apply the dilution of the mineral collagen solution obtained in step S1-2 for softening, curl it into a tube shape, and dry it until it is completely shaped; the dried collagen film needs to be diluted to be rolled into a tube of mineral collagen solution as a binder.

步骤S2-3:取步骤S2-2所得完全定型的管状产物,经交联剂交联后即得神经导管;Step S2-3: take the fully shaped tubular product obtained in step S2-2, and cross-link with a cross-linking agent to obtain a nerve conduit;

可选地,步骤S2-3还包括对交联剂交联后的产物进行洗脱、冻干处理,再采用辐照的方式对产品进行灭菌,制得胶原多层神经导管。Optionally, step S2-3 further includes eluting and freeze-drying the product cross-linked by the cross-linking agent, and then sterilizing the product by irradiation to prepare a collagen multilayer nerve conduit.

在本发明实施例中,所述模具中与矿物胶原溶液接触的一侧具有微米或纳米尺度的沟槽结构;In an embodiment of the present invention, the side of the mold in contact with the mineral collagen solution has a micro- or nano-scale groove structure;

在本发明实施例中,可选地,所述模具的材质采用单晶硅,在单晶硅表面通过干法刻蚀刻蚀出所述沟槽结构,或者所述纳米尺度的沟槽结构采用二甲基硅氧烷(PDMS)转模的方式将结构附加在矿化胶原薄膜。In the embodiment of the present invention, optionally, the material of the mold is monocrystalline silicon, and the trench structure is etched on the surface of the monocrystalline silicon by dry etching, or the nanoscale trench structure is made of two The structure was attached to the mineralized collagen film by means of methylsiloxane (PDMS) transfer molding.

在本发明实施例中,所述步骤S2-1中矿物胶原溶液倒入模具中风干前厚度为3-10mm;In the embodiment of the present invention, in the step S2-1, the mineral collagen solution is poured into the mold and the thickness is 3-10mm before air-drying;

在本发明实施例中,可选地,所述矿物胶原溶液含量为0.5-1g/cm2In the embodiment of the present invention, optionally, the content of the mineral collagen solution is 0.5-1 g/cm 2 ;

在本发明实施例中,可选地,所述干燥为风干,所述风干温度不低于室温,而且不高于30℃;In the embodiment of the present invention, optionally, the drying is air-drying, and the air-drying temperature is not lower than room temperature and not higher than 30°C;

可选地,根据风干时间不同,干燥程度可以控制(含最终水量不同),风干后膜厚度0.1-1mm。可以采取分层干燥的工艺,逐步添加含有不同矿物种类(β磷酸三钙,纳米羟基磷灰石,矿化胶原)矿物胶原溶液进行单张膜的制备,使其具有更高级的多种成分的结构。Optionally, depending on the air-drying time, the degree of drying can be controlled (the final water content is different), and the film thickness after air-drying is 0.1-1 mm. The process of layering and drying can be adopted, and the mineral collagen solution containing different mineral species (β-tricalcium phosphate, nano-hydroxyapatite, mineralized collagen) can be gradually added to prepare a single film, so that it has more advanced multi-component properties. structure.

在本发明实施例中,可选地,干燥后形成的矿物胶原薄膜的厚度0.1-1mm。In the embodiment of the present invention, optionally, the thickness of the mineral collagen film formed after drying is 0.1-1 mm.

在本发明实施例中,所述步骤S2-2中,所述矿物胶原溶液稀释液使用去离子水按体积比稀释,所述稀释浓度为1:(1~10)。In the embodiment of the present invention, in the step S2-2, the mineral collagen solution diluent is diluted by volume with deionized water, and the dilution concentration is 1:(1-10).

在本发明实施例中,所述步骤S2-3中,洗脱先用乙醇水溶液清洗3~10次,再用纯化水清洗3~10次,其中乙醇水溶液乙醇体积浓度范围为30%-100%。In the embodiment of the present invention, in the step S2-3, the elution is first washed with ethanol aqueous solution for 3-10 times, and then washed with purified water for 3-10 times, wherein the ethanol volume concentration range of the ethanol aqueous solution is 30%-100% .

在本发明实施例中,在步骤S2-3中所述冻干处理具体为:将洗脱后得到的产物先在-30~-20℃的条件下进行预冻,再在真空、-10~0℃的条件下进行升华造孔,孔径范围为0-10μm,最后在0~50℃下进行真空干燥;In the embodiment of the present invention, the freeze-drying treatment in step S2-3 is specifically: pre-freezing the product obtained after elution at -30~-20°C, and then under vacuum, -10~ The sublimation is carried out under the condition of 0 °C to make pores, the pore size is in the range of 0-10 μm, and finally vacuum drying is carried out at 0 to 50 °C;

优选地,所述孔径范围为1μm-10μm。Preferably, the pore size ranges from 1 μm to 10 μm.

在本发明实施例中,在步骤S2-3所述交联的交联时间为20min~4h;In the embodiment of the present invention, the cross-linking time of the cross-linking in step S2-3 is 20min-4h;

可选地,所述辐照所用的试剂为钴-60灭菌剂,剂量为15~38kGy。Optionally, the reagent used for the irradiation is cobalt-60 sterilant, and the dose is 15-38 kGy.

在本发明实施例中,所述I型胶原蛋白为牛源型胶原蛋白,经由牛跟腱常规提取获得,具体提取方法可参见以下步骤:(参考自:熊月琴,何小维.胶原基医用复合水凝胶的制备及性质研究[J].现代食品科技,2009,25(12):1454-1457.)In the embodiment of the present invention, the type I collagen is bovine-derived collagen, which is obtained by routine extraction from bovine Achilles tendon. The specific extraction method can refer to the following steps: (refer to: Xiong Yueqin, He Xiaowei. Collagen-based medical compound water Preparation and Properties of Gel[J].Modern Food Science and Technology, 2009,25(12):1454-1457.)

1)将新鲜牛跟腱洗净,刮去皮下脂肪,切成1cm×1cm的碎块,放入10%的NaCl溶液中浸泡过夜,以除去盐溶性蛋白和其它可溶性杂质。用蒸馏水洗涤3次后进行第1次脱脂(m牛跟腱:V脱脂液=1:10,脱脂液由6%的Na2CO3溶液和1%脱脂剂组成),30℃浸泡60min后用蒸馏水洗涤2~3次,然后进行第2次脱脂(m牛跟腱:V脱脂液=1:10,脱脂液由3%的Na2CO3溶液和1%脱脂剂组成),30℃搅拌60min后用30℃温水洗涤3次,于通风橱中晾干备用。1) Wash the fresh bovine Achilles tendon, scrape off the subcutaneous fat, cut into pieces of 1cm×1cm, and soak in 10% NaCl solution overnight to remove salt-soluble protein and other soluble impurities. After washing 3 times with distilled water, carry out the first degreasing (m bovine Achilles tendon: V degreasing solution = 1:10, degreasing solution consists of 6% Na 2 CO 3 solution and 1% degreaser), soak at 30 ° C for 60 min and then use Wash with distilled water for 2 to 3 times, and then carry out the second degreasing (m cattle Achilles tendon: V degreasing solution = 1:10, degreasing solution is composed of 3% Na 2 CO 3 solution and 1% degreaser), stirring at 30 ° C for 60 min After washing with 30 ℃ warm water 3 times, dry in a fume hood for later use.

2)将一定量的预处理过的牛跟腱原料加入含有胃蛋白酶的酸溶液(pH2.5~3)中处理一段时间,用两层医用纱布过滤。2) Add a certain amount of pretreated bovine Achilles tendon raw material to an acid solution (pH 2.5-3) containing pepsin for a period of time, and filter with two layers of medical gauze.

3)向滤液中直接加入NaCl固体进行盐析(NaCl最终浓度小于3.0mol/L),离心分离,得到胶原蛋白沉淀。盐析后得到的胶原蛋白沉淀溶解于所用酸溶液,在0.02mol/L的Na2HPO4(pH8.6)中透析2d,然后以蒸馏水为外透析液透析1d。得到牛源型I型胶原蛋白水凝胶。3) NaCl solid is directly added to the filtrate for salting out (the final concentration of NaCl is less than 3.0 mol/L), and centrifugation is performed to obtain collagen precipitation. The collagen precipitate obtained after salting out was dissolved in the acid solution used, dialyzed against 0.02mol/L Na 2 HPO 4 (pH 8.6) for 2 d, and then dialyzed with distilled water as the external dialysate for 1 d. A bovine-derived type I collagen hydrogel was obtained.

在本发明实施例中,所述纳米羟基磷灰石购自阿拉丁公司,货号H106378;In the embodiment of the present invention, the nano-hydroxyapatite is purchased from Aladdin Company, item number H106378;

在本发明实施例中,所述仿生矿化胶原(矿化胶原骨粉)购自奥精医药科技有限公司。In the examples of the present invention, the biomimetic mineralized collagen (mineralized collagen bone powder) was purchased from Aojing Pharmaceutical Technology Co., Ltd.

实施例1、制备多层人工神经导管Example 1. Preparation of multilayer artificial nerve conduit

本实施例中多层人工神经导管使用矿物胶原溶液进行制备,矿物胶原溶液的制备方法是:In the present embodiment, the multi-layer artificial nerve conduit is prepared by using a mineral collagen solution, and the preparation method of the mineral collagen solution is:

1、将I型胶原蛋白水凝胶与矿物材料混合,其质量比为5:1;所述矿物材料为仿生矿化胶原(粒度为70nm);1. Mix type I collagen hydrogel with a mineral material in a mass ratio of 5:1; the mineral material is biomimetic mineralized collagen (with a particle size of 70 nm);

2、上一步中的仿生矿化胶原、I型胶原蛋白水凝胶与水混合,其中加入的水的体积含量为仿生矿化胶原、I型胶原蛋白水凝胶与水总体积的10%,即得矿物胶原溶液。2. The biomimetic mineralized collagen and type I collagen hydrogel in the previous step are mixed with water, and the volume content of the added water is 10% of the total volume of the biomimetic mineralized collagen, type I collagen hydrogel and water, That is, the mineral collagen solution is obtained.

多层神经导管的制备方法是:The preparation method of the multilayered nerve conduit is:

1、将矿物胶原溶液100g平铺在模具中,所述模具与矿物胶原溶液的接触面采用单晶硅,单晶硅通过干法刻蚀出长与模具等长,宽10微米,深10微米,间距5微米的平行沟槽。1. Spread 100 g of the mineral collagen solution in the mold. The contact surface between the mold and the mineral collagen solution is made of single crystal silicon. The single crystal silicon is etched by dry method to have the same length as the mold, with a width of 10 microns and a depth of 10 microns. , parallel trenches with a pitch of 5 microns.

模具的尺寸为长*宽*高=20*10*2cm,溶液厚度为5mm,The size of the mold is length*width*height=20*10*2cm, the thickness of the solution is 5mm,

所述矿物胶原溶液的含量为0.5g/cm2,负压-0.1Mp排空气泡,将其于室温25℃自然风干至完全干燥,裁剪至20mm*50mm;其厚度为0.5mm,制备成膜;The content of the mineral collagen solution is 0.5g/cm 2 , the negative pressure is -0.1Mp to exhaust air bubbles, it is naturally air-dried at room temperature 25°C to completely dry, and cut to 20mm*50mm; its thickness is 0.5mm, and it is prepared into a film ;

2、均匀涂抹胶原蛋白稀释液(所述胶原蛋白稀释液按照矿物胶原溶液:水(v:v)=1:5混合)进行软化,将软化后的膜卷曲成管状(长20mm,内径5mm),所述卷曲形成的导管中,管壁中膜的层数为4层,经圆筒状模具固定常温25℃自然风干至完全干燥定型得到管状产物;2. Evenly apply the collagen dilution solution (the collagen dilution solution is mixed according to the mineral collagen solution: water (v:v)=1:5) for softening, and curl the softened membrane into a tube shape (length 20mm, inner diameter 5mm) , in the tube formed by the curling, the number of layers of the film in the tube wall is 4 layers, and the tubular product is obtained by fixing the cylindrical mold at room temperature and air-drying to complete drying and shaping;

3、将所得管状产物浸入200mL EDC水溶液中,所述EDC溶液浓度为10g/mL,交联30min,将交联后的管状产物在50%(v:v)乙醇水溶液洗脱,乙醇水溶液清洗3次,在用纯化水清洗3次、-20℃预冻后,再在真空-5℃下冷冻干燥升华造孔48小时,孔径为5μm,最后再30℃下进行真空干燥。最后进行辐照灭菌,使用钴-60灭菌剂,剂量为15kGy,得到多层人工神经导管,所述神经导管内管壁设有与模具等长,宽10微米,深10微米,间距5微米的平行沟槽。神经导管长20mm,内径5mm,管壁中膜的层数为4层,壁厚2mm。如图1所示。神经导管干燥前后的尺寸变化可忽略不计。3. Immerse the obtained tubular product in 200 mL of EDC aqueous solution, the concentration of the EDC solution is 10 g/mL, cross-link for 30 min, elute the cross-linked tubular product in 50% (v:v) ethanol aqueous solution, and wash with ethanol aqueous solution for 3 Second, after washing with purified water for 3 times, pre-freezing at -20 °C, freeze-drying and sublimation at -5 °C in vacuum for 48 hours to create pores with a pore size of 5 μm, and finally vacuum drying at 30 °C. Finally, sterilize by irradiation, using cobalt-60 sterilant at a dose of 15kGy to obtain a multilayer artificial nerve conduit. micron parallel grooves. The nerve conduit is 20 mm long and 5 mm in inner diameter. The number of layers of the tunica media is 4, and the wall thickness is 2 mm. As shown in Figure 1. Dimensional changes before and after nerve conduit drying were negligible.

实施例2Example 2

本实施例中多层人工神经导管使用矿物胶原溶液进行制备,矿物胶原溶液的制备方法是:In the present embodiment, the multi-layer artificial nerve conduit is prepared by using a mineral collagen solution, and the preparation method of the mineral collagen solution is:

其中,矿物胶原溶液的制备方法是:Wherein, the preparation method of mineral collagen solution is:

1、将I型胶原蛋白水凝胶与矿物材料混合,其质量比为6:1;所述矿物材料为纳米羟基磷灰石(粒度为85nm);1. Mix type I collagen hydrogel with a mineral material, and the mass ratio is 6:1; the mineral material is nano-hydroxyapatite (particle size is 85nm);

2、上一步中得到的纳米羟基磷灰石、I型胶原蛋白水凝胶与水混合,其中加入的水的体积含量为20%,即得矿物胶原溶液。2. The nano-hydroxyapatite and type I collagen hydrogel obtained in the previous step are mixed with water, and the volume content of the added water is 20% to obtain a mineral collagen solution.

多层神经导管的制备方法是:The preparation method of the multilayered nerve conduit is:

1、将矿物胶原溶液100g平铺在模具中,所述模具与矿物胶原溶液的接触面采用单晶硅,单晶硅通过干法刻蚀出长与模具等长,宽15微米,深15微米,间距5微米的平行沟槽。1. Spread 100 g of the mineral collagen solution in the mold. The contact surface between the mold and the mineral collagen solution is made of monocrystalline silicon. The monocrystalline silicon is etched by dry method to have the same length as the mold, 15 microns in width and 15 microns in depth. , parallel trenches with a pitch of 5 microns.

模具的尺寸为长*宽*高=20*10*2cm,溶液厚度为5mm,The size of the mold is length*width*height=20*10*2cm, the thickness of the solution is 5mm,

所述矿物胶原溶液的含量为0.5g/cm2,负压-0.1Mp排空气泡,将其于室温25℃自然风干至完全干燥,裁剪至20mm*50mm;其厚度为0.3mm,制备成膜;The content of the mineral collagen solution is 0.5g/cm 2 , the negative pressure is -0.1Mp to exhaust air bubbles, it is naturally air-dried at room temperature 25°C to completely dry, and cut to 20mm*50mm; its thickness is 0.3mm, and it is prepared into a film ;

2、匀涂抹胶原蛋白稀释液(所述胶原蛋白稀释液按照矿物胶原溶液:水(v:v)=1:4混合)进行软化,将软化后的膜卷曲成管状(长20mm,内径5mm),所述卷曲形成的导管中,管壁中膜的层数为5层,经圆筒状模具固定常温25℃自然风干至完全干燥定型得到管状产物;2. Evenly apply the collagen dilution solution (the collagen dilution solution is mixed according to the mineral collagen solution: water (v:v)=1:4) for softening, and curl the softened membrane into a tube shape (length 20mm, inner diameter 5mm) , in the tube formed by the curling, the number of layers of the film in the tube wall is 5 layers, and the tubular product is obtained by fixing the cylindrical mold at room temperature and air-drying to complete drying and shaping;

3、将所得管状产物浸入200mL戊二醛水溶液中,所述戊二醛水溶液体积浓度为0.5%,交联2h,将交联后的管状产物在80%(v:v)乙醇水溶液洗脱,乙醇水溶液清洗3次,在用纯化水清洗3次、-25℃预冻后,再在真空-5℃下冷冻干燥升华造孔72小时,孔径为5μm,最后再30℃下进行真空干燥。最后进行辐照灭菌,使用钴-60灭菌剂,剂量为15kGy,得到多层人工神经导管,所述神经导管内管壁设有与模具等长,宽15微米,深15微米,间距5微米的平行沟槽。神经导管长20mm,内径5mm,管壁中膜的层数为5层,壁厚1.5mm。神经导管干燥前后的尺寸变化可忽略不计。3. Immerse the obtained tubular product in 200 mL of glutaraldehyde aqueous solution, the volume concentration of the glutaraldehyde aqueous solution is 0.5%, cross-link for 2 hours, and elute the cross-linked tubular product in 80% (v:v) ethanol aqueous solution, The ethanol solution was washed three times, washed three times with purified water, pre-frozen at -25 °C, and then freeze-dried and sublimated at -5 °C in vacuum for 72 hours to create pores with a pore size of 5 μm, and finally vacuum-dried at 30 °C. Finally, sterilize by irradiation, use cobalt-60 sterilant at a dose of 15kGy, to obtain a multilayer artificial nerve conduit. micron parallel grooves. The nerve conduit is 20 mm long and 5 mm in inner diameter. The number of layers of the tunica media is 5, and the wall thickness is 1.5 mm. Dimensional changes before and after nerve conduit drying were negligible.

对比例1Comparative Example 1

按照实施例1的方法制备内径5mm,壁厚2mm,长20mm,管壁中膜的层数为4层,不含仿生矿化胶原的纯胶原多层导管,除不含仿生矿化胶原这一区别外,其余制备原料及其用量,制备过程均与实施例1相同。The inner diameter of 5mm, the wall thickness of 2mm, and the length of 20mm were prepared according to the method of Example 1. The number of layers in the tube wall was 4 layers. Except for the difference, the rest of the preparation raw materials and their dosages, and the preparation process are the same as those in Example 1.

对比例2Comparative Example 2

按照实施例2的方法制备内径5mm,壁厚1.5mm,长20mm,管壁中膜的层数为5层,不含纳米羟基磷灰石的纯胶原多层导管,除不含纳米羟基磷灰石这一区别外,其余制备原料及其用量,制备过程均与实施例2相同。According to the method of Example 2, the inner diameter of 5mm, the wall thickness of 1.5mm, the length of 20mm, the number of layers of the membrane in the tube wall is 5, and the pure collagen multilayer catheter without nano-hydroxyapatite is prepared, except that it does not contain nano-hydroxyapatite Except this difference of stone, other preparation raw materials and their consumption, preparation process are all identical with embodiment 2.

应用例1Application example 1

生理盐水浸泡5分钟后,通过WDW电子万能试验机测试两种样品的拉伸强度如表1所示:After being soaked in physiological saline for 5 minutes, the tensile strength of the two samples was tested by WDW electronic universal testing machine, as shown in Table 1:

表1:力学性能测试统计表Table 1: Statistical table of mechanical properties test

Figure BDA0002380544390000131
Figure BDA0002380544390000131

从表1和图4中可以看出,实施例1和2制备的胶原矿物导管能够满足缝合阶段对导管力学性能的要求。It can be seen from Table 1 and Figure 4 that the collagen mineral catheters prepared in Examples 1 and 2 can meet the requirements for the mechanical properties of the catheter in the suturing stage.

应用例2、多层人工导管用于大鼠坐骨神经的修复Application example 2. Multilayer artificial catheter for the repair of rat sciatic nerve

按照实施例1的方法制备多层人工神经导管,其中长20mm,内径5mm。The multilayer artificial nerve conduit was prepared according to the method of Example 1, wherein the length was 20 mm and the inner diameter was 5 mm.

以成年雌性Spragne-Dawley大鼠坐骨神经损伤模型:大鼠称重后腹腔注射戊巴比妥钠麻醉,将大鼠俯卧位固定于操作台上,术区脱毛备皮,酒精消毒,沿右侧髂脊做长约2cm斜行直切口,显露坐骨神经,用纤维剪刀在神经外衣与周围组织之间轻轻做锐性分离以充分游离坐骨神经,上下约游离2cm长度神经,沿神经分叉上方处剪断神经,神经弹性回缩,近端剪短一定长过度造成10mm神经缺损。把上述导管移植到损伤的局部,将两侧的神经断端插入上述导管中,将该导管与神经重叠的部分用10-0尼龙线缝合,动态观察1年,并进行形态学、电生理学和行为学的评价。Taking the adult female Spragne-Dawley rat model of sciatic nerve injury: the rats were weighed and then anesthetized by intraperitoneal injection of sodium pentobarbital, and the rats were fixed on the operating table in a prone position. Make an oblique straight incision about 2 cm long on the spine to expose the sciatic nerve, and use fiber scissors to gently separate the sciatic nerve between the nerve coat and surrounding tissue to fully dissociate the sciatic nerve. , nerve elastic retraction, the proximal end is cut short and a certain length is too long to cause a 10mm nerve defect. The above-mentioned catheter was transplanted to the injured part, and the broken ends of the nerves on both sides were inserted into the above-mentioned catheter, and the overlapping part of the catheter and the nerve was sutured with 10-0 nylon thread, and the dynamic observation was carried out for 1 year. Behavioural evaluation.

研究结果表明,进行移植手术后第3个月,动物的行为障碍开始恢复,第6个月已经无明显行动障碍,第12个月在无负重的情况下已经恢复正常。采用WGA-HRP进行神经示踪、Neurfilament(NF)免疫组织化学染色证明有形态结构的重建;氯化金染色证明有运动终板的恢复。在电生理学的研究中也证明了躯体感觉诱发电位(SEP)和运动诱发电位(MEP)的恢复。The results of the study showed that the behavioral disorders of the animals began to recover in the 3rd month after the transplantation, there was no obvious movement disorder in the 6th month, and the animals returned to normal in the 12th month without weight bearing. WGA-HRP was used for nerve tracing, and Neurfilament (NF) immunohistochemical staining demonstrated the reconstruction of morphological structures; gold chloride staining demonstrated the recovery of motor endplates. Recovery of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) has also been demonstrated in electrophysiological studies.

应用例3Application example 3

采用本发明实施例1制得的矿化胶原-胶原多层神经导管对成年Spragne-Dawley大鼠10mm坐骨神经缺损修复的效果进行评估,并和自体神经移植修复、胶原蛋白导管修复(对比例1)、进行了比较,实验结果动态观察12周,进行组织学、电生理学和行为学的评价结果如下:Using the mineralized collagen-collagen multi-layered nerve conduit prepared in Example 1 of the present invention to evaluate the effect of repairing 10 mm sciatic nerve defect in adult Spragne-Dawley rats, and repairing it with autologous nerve transplantation and collagen conduit repair (Comparative Example 1) , were compared, the experimental results were dynamically observed for 12 weeks, and the evaluation results of histology, electrophysiology and behavior were as follows:

1、组织学方面:矿化胶原-胶原多层神经导管组在有髓纤维密度,髓鞘厚度虽不及自体神经,但其显著优于纯胶原蛋白导管组(P<0.05),其在有髓纤维直径方面三组差异不大(p>0.05)(如表2,图6所示)。矿化胶原-胶原多层神经导管组腓肠肌湿重恢复率与自体神经组无统计学差异(p>0.05),且显著优于纯胶原蛋白导管组(p<0.05)(表3)。1. Histological aspect: the mineralized collagen-collagen multilayer nerve conduit group was significantly better than the pure collagen conduit group in the density of myelinated fibers and the thickness of the myelin sheath was not as good as that of the autologous nerve (P<0.05). There was little difference between the three groups in terms of fiber diameter (p>0.05) (as shown in Table 2, Figure 6). The recovery rate of gastrocnemius muscle wet weight in the mineralized collagen-collagen multilayer nerve conduit group was not statistically different from that in the autologous nerve group (p>0.05), and was significantly better than that in the pure collagen conduit group (p<0.05) (Table 3).

2、电生理学方面,矿化胶原-胶原多层神经导管组修复神经传导速率与自体神经组无统计学差异(p>0.05),并且显著优于纯胶原蛋白导管组(p<0.05);修复神经波幅恢复程度与纯胶原蛋白导管组相近(p>0.05)(表4)。2. In terms of electrophysiology, the repaired nerve conduction rate of the mineralized collagen-collagen multilayer nerve conduit group was not statistically different from that of the autologous nerve group (p>0.05), and was significantly better than the pure collagen conduit group (p<0.05). The degree of nerve amplitude recovery was similar to that of the pure collagen catheter group (p>0.05) (Table 4).

4、行为学评估,矿化胶原-胶原多层神经导管组的坐骨神经功能指数(SFI)恢复程度虽不及自体神经组(P<0.05),但其显著优于纯胶原蛋白导管组(P<0.05)(表5)。4. Behavioral evaluation, the recovery degree of sciatic nerve function index (SFI) in the mineralized collagen-collagen multilayer nerve conduit group was not as good as that in the autologous nerve group (P<0.05), but it was significantly better than that in the pure collagen conduit group (P<0.05). )(table 5).

表2、再生神经组织学评价:再生神经中点横截面透射电镜观察Table 2. Histological evaluation of regenerated nerves: transmission electron microscope observation of the midpoint of regenerated nerves

Figure BDA0002380544390000141
Figure BDA0002380544390000141

表3、再生肌肉组织学评价:腓肠肌湿重恢复率(%)Table 3. Histological evaluation of regenerated muscle: wet weight recovery rate of gastrocnemius muscle (%)

腓肠肌湿重恢复率Gastrocnemius wet weight recovery rate 矿化胶原-胶原多层神经导管组Mineralized Collagen-Collagen Multilayer Nerve Duct Group 39.8039.80 纯胶原蛋白导管组Pure Collagen Catheter Set 36.4636.46 自体神经组autologous nerve group 48.2948.29

表4、电生理学评价:复合肌肉动作电位(CMAP)Table 4. Electrophysiological evaluation: compound muscle action potential (CMAP)

Figure BDA0002380544390000151
Figure BDA0002380544390000151

表5、行为学的评价:坐骨神经功能指数(SFI)Table 5. Behavioral evaluation: sciatic nerve function index (SFI)

SFISFI 矿化胶原-胶原多层神经导管组Mineralized Collagen-Collagen Multilayer Nerve Duct Group -73.75-73.75 纯胶原蛋白导管组Pure Collagen Catheter Set -82.79-82.79 自体神经组autologous nerve group -61.92-61.92

研究结果表明,在术后12周,矿化胶原-胶原多层神经导管在组织学、电生理学及行为学等方面均优于纯胶原蛋白导管组,甚至个别方面接近自体神经组,证明本发明相比纯胶原蛋白导管具有优异的神经修复作用。The results of the study showed that the mineralized collagen-collagen multilayer nerve conduit was superior to the pure collagen conduit group in histological, electrophysiological and behavioral aspects at 12 weeks after the operation, and even approached the autologous nerve group in some aspects, proving the present invention. Compared with pure collagen catheters, it has excellent nerve repair effect.

虽然本发明所揭露的实施方式如上,但所述的内容仅为便于理解本发明而采用的实施方式,并非用以限定本发明。任何本发明所属领域内的技术人员,在不脱离本发明所揭露的精神和范围的前提下,可以在实施的形式及细节上进行任何的修改与变化,但本发明的专利保护范围,仍须以所附的权利要求书所界定的范围为准。Although the embodiments disclosed in the present invention are as above, the described contents are only the embodiments adopted to facilitate the understanding of the present invention, and are not intended to limit the present invention. Any person skilled in the art to which the present invention belongs, without departing from the spirit and scope disclosed by the present invention, can make any modifications and changes in the form and details of the implementation, but the scope of the patent protection of the present invention still needs to be The scope defined by the appended claims shall prevail.

Claims (15)

1. A nerve conduit is a conduit formed by mixing and solidifying type I collagen hydrogel and a mineral material to prepare a membrane and then curling the membrane;
optionally, the surface of the prepared membrane is provided with a groove structure with a micrometer scale or nanometer scale, and the surface of the membrane containing the groove structure is used for the inner wall of the nerve conduit;
preferably, the trench structure has a dimension of 25000 μm long, 5-25 μm wide, 5-25 μm deep, and 5-25 μm spacing, or a dimension of 10-20 μm long, 100-200nm wide, 100-200nm deep, and 100-200nm spacing.
2. The nerve conduit of claim 1, wherein the mass ratio of the mineral material to the collagen type I hydrogel is 1 (1-10).
3. A nerve conduit according to claim 1, wherein the mineral material comprises one or more of β tricalcium phosphate, nano-hydroxyapatite and biomimetic mineralized collagen;
preferably, the mineral material has a particle size of 50-100 nm.
4. A nerve conduit according to any one of claims 1 to 3, wherein the wall of the coil-formed conduit is physically or chemically reinforced to enhance fixation between different membrane layers;
preferably, the chemical method is cross-linking the collagen using a cross-linking agent.
5. The nerve conduit of claim 4, wherein the cross-linking agent is selected from a first one or more of glutaraldehyde, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC), an epoxy cross-linking agent, and genipin;
the epoxy crosslinking agent is selected from one or more of ethylene oxide and epichlorohydrin.
6. A nerve conduit according to any one of claims 1 to 3, wherein the inner catheter diameter of the nerve conduit is 1-5 mm; the length of the conduit is 10-30 mm; in the curled catheter, the number of the membrane layers in the catheter wall is 2-6.
7. The nerve conduit of any one of claims 1 to 3, wherein the collagen type I hydrogel and mineral material are mixed with water and then formed into a film by a mold;
optionally, water is added in an amount of 0% to 50% of the total volume of the collagen type I hydrogel, the mineral material and the water.
8. The nerve conduit of claim 7, wherein said preparing a film by a mold comprises the steps of,
pouring a solution formed by mixing the type I collagen hydrogel and the mineral material with water into a mold, vacuumizing under negative pressure to remove internal bubbles, and drying to form a film-shaped material;
optionally, the pressure of the negative pressure vacuum pumping is-0 to-0.1 MPa.
9. The method for preparing a nerve conduit according to any one of claims 4 to 8, comprising the following operating steps:
step S1-1: mixing the type I collagen hydrogel with a mineral material to obtain a mineral material/type I collagen hydrogel mixture;
step S1-2: mixing the mineral material/type I collagen hydrogel mixture obtained in the step S1-1 with water to obtain a mineral collagen solution;
step S2-1: pouring the mineral collagen solution obtained in the step S1-2 into a mould, removing internal bubbles through negative pressure vacuum pumping, and drying to form a film-shaped mineral collagen film;
step S2-2: uniformly coating the mineral collagen film obtained in the step S2-1 with a diluent of the mineral collagen solution obtained in the step S1-2, softening, curling into a tube shape, and drying until the shape is completely fixed;
step S2-3: taking the completely-shaped tubular product obtained in the step S2-2, and crosslinking the tubular product by using a crosslinking agent to obtain the nerve conduit;
optionally, step S2-3 further includes eluting and lyophilizing the product after cross-linking with the cross-linking agent, and then sterilizing the product by irradiation to obtain the collagen multi-layer nerve conduit.
10. The method for preparing a nerve conduit according to claim 9, wherein the side of the mold in contact with the mineral collagen solution has a groove structure of a micro or nano scale;
optionally, the mold is made of monocrystalline silicon, the groove structure is etched on the surface of the monocrystalline silicon by dry etching, or the nano-scale groove structure is attached to the mineralized collagen film by a mode of dimethyl siloxane (PDMS) conversion.
11. The method for manufacturing a nerve conduit according to claim 9, wherein the mineral collagen solution has a thickness of 3 to 10mm before being poured into a mold for air-drying in the step S2-1;
optionally, the mineral collagen solution is present in an amount of 0.5-1g/cm2
Optionally, the drying is air drying, and the air drying temperature is not lower than room temperature and not higher than 30 ℃;
optionally, the mineral collagen film formed after drying has a thickness of 0.1-1 mm.
12. The method for preparing a nerve conduit according to claim 9, wherein in the step S2-2, the mineral collagen solution diluent is diluted by deionized water according to a volume ratio, and the dilution concentration is 1 (1-10).
13. The method for preparing a nerve conduit according to claim 9, wherein in the step S2-3, the elution is washed with an ethanol aqueous solution for 3-10 times and then with purified water for 3-10 times, wherein the ethanol concentration of the ethanol aqueous solution is 30% -100% by volume.
14. The method for manufacturing a nerve conduit according to claim 9, wherein the lyophilization process in step S2-3 is specifically: pre-freezing the product obtained after elution at-30 to-20 ℃, carrying out sublimation pore-forming at-10 to 0 ℃ in vacuum, wherein the pore diameter is 0 to 10 mu m, and finally carrying out vacuum drying at 0 to 50 ℃;
preferably, the pore size ranges from 1 μm to 10 μm.
15. The method for manufacturing a nerve conduit according to claim 9, wherein the crosslinking time of the crosslinking at step S2-3 is 20min to 4 h;
optionally, the reagent used for irradiation is a cobalt-60 sterilizing agent, and the dosage is 15-38 kGy.
CN202010081724.9A 2020-02-06 2020-02-06 Nerve conduit and preparation method thereof Pending CN111317867A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010081724.9A CN111317867A (en) 2020-02-06 2020-02-06 Nerve conduit and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010081724.9A CN111317867A (en) 2020-02-06 2020-02-06 Nerve conduit and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111317867A true CN111317867A (en) 2020-06-23

Family

ID=71163330

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010081724.9A Pending CN111317867A (en) 2020-02-06 2020-02-06 Nerve conduit and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111317867A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112870451A (en) * 2021-03-02 2021-06-01 山东奥精生物科技有限公司 Nerve sheath tube and preparation method and application thereof
CN112957529A (en) * 2021-02-01 2021-06-15 天新福(北京)医疗器材股份有限公司 Multilayer memory type nerve conduit and preparation method and application thereof
CN114081999A (en) * 2021-11-16 2022-02-25 清华大学 Composite nerve conduit and preparation method thereof
CN114533336A (en) * 2022-02-28 2022-05-27 上海全威生物科技有限公司 Nerve or blood vessel protection sheath and application thereof
CN115970064A (en) * 2023-01-17 2023-04-18 北京大学人民医院 A kind of elastic self-curling peripheral nerve repair membrane and its preparation method and application
CN119700423A (en) * 2024-12-26 2025-03-28 杭州师范大学附属医院(杭州市第二人民医院) An adjustable soft clamp device for protecting the chorda tympani nerve during surgery

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258729A1 (en) * 2001-09-11 2004-12-23 Czernuszka Jan Tadeusz Tissue engineering scaffolds
CN1562383A (en) * 2004-03-16 2005-01-12 武汉理工大学 Aretificial nerve canula material of slow operating complex type poly lactic acid and preparation method
EP2380601A1 (en) * 2010-04-15 2011-10-26 National University of Ireland, Galway Multichannel collagen nerve conduit for nerve repair
CN105310794A (en) * 2015-02-14 2016-02-10 李贵才 Method for preparing porous artificial nerve conduit with orientation structures on inner walls

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258729A1 (en) * 2001-09-11 2004-12-23 Czernuszka Jan Tadeusz Tissue engineering scaffolds
CN1562383A (en) * 2004-03-16 2005-01-12 武汉理工大学 Aretificial nerve canula material of slow operating complex type poly lactic acid and preparation method
EP2380601A1 (en) * 2010-04-15 2011-10-26 National University of Ireland, Galway Multichannel collagen nerve conduit for nerve repair
CN105310794A (en) * 2015-02-14 2016-02-10 李贵才 Method for preparing porous artificial nerve conduit with orientation structures on inner walls

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
朱庆棠: "《周围神经缺损修复材料的生物制造与临床评估》", 30 September 2018 *
申智敏等: "构建Ⅰ型胶原蛋白神经导管及其在前臂正中神经损伤重建中的作用机制", 《中国组织工程研究》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112957529A (en) * 2021-02-01 2021-06-15 天新福(北京)医疗器材股份有限公司 Multilayer memory type nerve conduit and preparation method and application thereof
CN112957529B (en) * 2021-02-01 2022-02-11 天新福(北京)医疗器材股份有限公司 Multilayer memory type nerve conduit and preparation method and application thereof
CN112870451A (en) * 2021-03-02 2021-06-01 山东奥精生物科技有限公司 Nerve sheath tube and preparation method and application thereof
CN114081999A (en) * 2021-11-16 2022-02-25 清华大学 Composite nerve conduit and preparation method thereof
CN114533336A (en) * 2022-02-28 2022-05-27 上海全威生物科技有限公司 Nerve or blood vessel protection sheath and application thereof
CN115970064A (en) * 2023-01-17 2023-04-18 北京大学人民医院 A kind of elastic self-curling peripheral nerve repair membrane and its preparation method and application
CN119700423A (en) * 2024-12-26 2025-03-28 杭州师范大学附属医院(杭州市第二人民医院) An adjustable soft clamp device for protecting the chorda tympani nerve during surgery

Similar Documents

Publication Publication Date Title
Chowdhury et al. Collagen type I: A versatile biomaterial
CN111317867A (en) Nerve conduit and preparation method thereof
Ågren Wound healing biomaterials-volume 2: functional biomaterials
Ludwicka et al. Medical and cosmetic applications of bacterial nanocellulose
JP5289772B2 (en) Cartilage-like structure having multi-layer structure and osteochondral substitute and use thereof
CN105705172B (en) Hydrophilic electrostatic spinning biological composite scaffold material for tissue regeneration and preparation method and application thereof
CN105688274B (en) A kind of preparation process of polycaprolactone/gelatin electrospinning compound rest
DE10135275A1 (en) Implant and process for its manufacture
WO2010081408A1 (en) Bioactive tissue regeneration film and preparation method thereof
CN101998862A (en) Collagen products and methods for producing collagen products
JPH09122227A (en) Medical material and manufacturing method thereof
CN103480042B (en) Artificial dura mater spinalis, and preparation method and use method thereof
US20180272038A1 (en) Polymeric mesh with selective permeability, for the repair and regeneration of tissues
Sachdev IV et al. A review on techniques and biomaterials used in 3D bioprinting
Liu et al. A novel use of genipin-fixed gelatin as extracellular matrix for peripheral nerve regeneration
JP2023533572A (en) Bridging the Peripheral Nerve Cleft with Conduits for Enhanced Nerve Regeneration
CN102813961A (en) Injection gel containing submicron hyaluronic acid microspheres and preparation method thereof
CN110743040A (en) Bionic skeletal muscle composite tissue prepared by multi-channel extrusion 3D biological printing
JP7168937B2 (en) Yarn and its manufacturing method
CN1258591C (en) Tissue engineered peripheral nerve graft
CN1580255A (en) Tissue engineered peripheral nerve graft
DE102009024133A1 (en) Bacterial nanocellulose for cartilage regeneration
CN108853581B (en) High-molecular polymer hydrogel composite Medpor prosthetic eye holder and preparation method thereof
JP2005213449A (en) Gelatin sponge
US20220305177A1 (en) Thread and method for preparing same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200623